Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine

Ítems similars

• Post-Catalytic Complexes with Emtricitabine or Stavudine and HIV-1 Reverse Transcriptase Reveal New Mechanistic Insights for Nucleotide Incorporation and Drug Resistance
  per: Nicole Bertoletti, et al.
  Publicat: (2020-10-01)
• Post-Catalytic Complexes with Emtricitabine or Stavudine and HIV-1 Reverse Transcriptase Reveal New Mechanistic Insights for Nucleotide Incorporation and Drug Resistance
  per: Bertoletti, Nicole, et al.
  Publicat: (2020)
• Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors
  per: Hurwitz, Selwyn J., et al.
  Publicat: (2012)
• Centrosome Amplification Induced by the Antiretroviral Nucleoside Reverse Transcriptase Inhibitors Lamivudine, Stavudine and Didanosine
  per: Yu, Mia, et al.
  Publicat: (2009)
• Inhibition of multi-drug resistant HIV-1 reverse transcriptase by nucleoside β-triphosphates
  per: Dash, Chandravanu, et al.
  Publicat: (2011)